In vivo targeting of lentiviral vectors pseudotyped with the Tupaia paramyxovirus H glycoprotein bearing a cell-specific ligand

Despite their exceptional capacity for transgene delivery ex vivo, lentiviral (LV) vectors have been slow to demonstrate clinical utility in the context of in vivo applications. Unresolved safety concerns related to broad LV vector tropism have limited LV vectors to ex vivo applications. Here, we re...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Ther Methods Clin Dev
Main Authors: Argaw, Takele, Marino, Michael P., Timmons, Andrew, Eldridge, Lindsey, Takeda, Kazuyo, Li, Pingjuan, Kwilas, Anna, Ou, Wu, Reiser, Jakob
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Gene & Cell Therapy 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8166926/
https://ncbi.nlm.nih.gov/pubmed/34141822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2021.04.012
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares